Advanced Parkinson’s patients can spend hours each day locked in ‘OFF’ states, periods when tremors, rigidity and immobility return as oral medications wear off. The first multi-country real-world data on continuous 24-hour foslevodopa/foscarbidopa infusion shows the approach cut that OFF time by 2.7 hours daily at six months, with improvements across motor symptoms, sleep, pain,… The post First real-world look: AbbVie’s 24-hour foslevodopa/foscarbidopa pump shows symptom gains in P...
